Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical factors and vascular endothelial growth factor as determinants of disease progression in Indian patients with amyotrophic lateral sclerosis.
Thomas A, Garg D, Srivastava AK, Kumar A, Pandit AK, Vibha D, Vivekanandhan S, Shukla G, Prasad K. Thomas A, et al. Among authors: srivastava ak. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Feb;25(1-2):46-52. doi: 10.1080/21678421.2023.2256362. Epub 2023 Sep 14. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 37710422
Genomics of rare genetic diseases-experiences from India.
GUaRDIAN Consortium; Sivasubbu S, Scaria V. GUaRDIAN Consortium, et al. Hum Genomics. 2019 Sep 25;14(1):52. doi: 10.1186/s40246-019-0215-5. Hum Genomics. 2019. PMID: 31554517 Free PMC article. Review.
Zonisamide add-on in tremor-dominant Parkinson's disease- A randomized controlled clinical trial.
Pillai KS, Bhat P, Srivastava AK, Rajan R, Radhakrishnan DM, Elavarasi A, Srivastava MP, Singh MB, Vishnu VY, Prasad K, Pandit AK, Goyal V. Pillai KS, et al. Among authors: srivastava mp, srivastava ak. Parkinsonism Relat Disord. 2022 Dec;105:1-6. doi: 10.1016/j.parkreldis.2022.10.017. Epub 2022 Oct 25. Parkinsonism Relat Disord. 2022. PMID: 36323130 Clinical Trial.
Escalate: Linezolid as an add on treatment in the intensive phase of tubercular meningitis. A randomized controlled pilot trial.
Sahib A, Bhatia R, Srivastava MVP, Singh MB, Komakula S, Vishnu VY, Rajan R, Gupta A, Srivastava AK, Wig N, Vikram NK, Biswas A. Sahib A, et al. Among authors: srivastava mvp, srivastava ak. Tuberculosis (Edinb). 2023 Sep;142:102351. doi: 10.1016/j.tube.2023.102351. Epub 2023 Jun 30. Tuberculosis (Edinb). 2023. PMID: 37394301 Clinical Trial.
2,115 results